Clinical observation of advanced NSCLC in the aged treated by gemcitabine combined with cisplatin
- VernacularTitle:健择联合顺铂治疗老年晚期非小细胞肺癌临床观察
- Author:
Qisen GUO
;
Hui JIA
;
Mingyong HAN
- Publication Type:Journal Article
- Keywords:
NSCLC Drug therapy Gemcitabine Cisplatin
- From:
Chinese Journal of Practical Internal Medicine
2003;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To Observe the effects of combination regimen of gemcitabine and cisplatin in treating advanced non-small cell lung cancer (NSCLC).Methods 30 patients with advanced NSCLC were treated with GP(GEMZAR 1000mg/m2 d1,8;CDDP 25mg/m2 d1～3 ).The course was repeated every 3 weeks for at least 2 cycles.Results The overall response rate was 36.7%(11/30),whereas 13 patients had stable disease and 6 patients showed progressive disease.The response rate was 46% in untreated patients and 29% was obtained in treated ones.Significant difference was observed between the two groups (P
